The Adrenal Receptor for Angiotensin II is Altered in Essential Hypertension
AUTOR(ES)
Williams, Gordon H.
RESUMO
To determine the mechanism underlying altered adrenal responsiveness in patients with essential hypertension, the renin-angiotensin-aldosterone axis was assessed in normotensive and hypertensive subjects using three pharmacological probes: SQ 20881, a converting enzyme inhibitor; saralasin, a competitive angiotensin antagonist with prominent agonist properties; and angiotensin itself. All subjects were studied while supine and in balance on a 10 meq Na/100 meq K intake. The decrement in plasma aldosterone with SQ 20881 in 26 hypertensive subjects (15±3 ng/dl) was normal (13±4 ng/dl), suggesting that the altered adrenal responsiveness in hypertensives is not because of a change in a postreceptor event or in the relative contribution of angiotensin to the control of aldosterone secretion.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=371969Documentos Relacionados
- Increased Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension
- Abnormal Adrenal Responsiveness and Angiotensin II Dependency in High Renin Essential Hypertension
- Decreased Adrenal Responsiveness to Angiotensin II: A Defect Present in Spontaneously Hypertensive Rats: A POSSIBLE MODEL OF HUMAN ESSENTIAL HYPERTENSION
- Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
- Mechanism of adrenal angiotensin II receptor changes after nephrectomy in rats.
